OptimizeRx Corp (NAS:OPRX)
$ 5.33 0.34 (6.81%) Market Cap: 98.18 Mil Enterprise Value: 117.77 Mil PE Ratio: 0 PB Ratio: 0.85 GF Score: 67/100

Q4 2023 OPTIMIZERx Corp Earnings Call Transcript

Mar 28, 2024 / 12:30PM GMT
Release Date Price: $12.15
Operator

Good morning, everyone, and thank you for joining optimize our exit Q4 fiscal 2023 conference call. With us today is the Chief Executive Officer of Optimized Rx, William Febbo. He's joined by Chief Financial Officer, Ed Stelmakh; President, Steve Silvestro; General Counsel, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D'Silva.

At the conclusion of today's call, I will provide some important cautions regarding forward-looking statements made by management management during today's call. I would like to remind everyone that today's call is being recorded and will be made a vailable for replay via webcast and a transcript and a link to the audio recording of this conference call will be provided on the Investors section of the come website.

Now I would like to turn the call over to Optimized Rx CEO, William Febbo . Sir, please go ahead.

William Febbo
OPTIMIZERx Corp - Chief Executive Officer, Director

Good morning, and thank you for joining our conference call to discuss fourth quarter 2023, the preliminary

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot